TOT BIOPHARM International Co Ltd
HKEX:1875
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TOT BIOPHARM International Co Ltd
HKEX:1875
|
CN |
|
W
|
Winpac Inc
KOSDAQ:097800
|
KR |
|
SAI Leisure Group Co Ltd
HKEX:1832
|
HK |
|
CD Projekt SA
OTC:OTGLF
|
PL |
|
Bigbloc Construction Ltd
NSE:BIGBLOC
|
IN |
|
V
|
Vintage Wine Estates Inc
NASDAQ:VWE
|
US |
|
Z
|
Zhejiang HangKe Technology Incorporated Co
SSE:688006
|
CN |
|
Bosideng International Holdings Ltd
OTC:BSDGY
|
HK |
|
G
|
Guizhou Qianyuan Power Co Ltd
SZSE:002039
|
CN |
|
Fast Finance 24 Holding AG
XETRA:FF24
|
DE |
|
Zambal Spain Socimi SA
MAD:YZBL
|
ES |
|
A
|
Apple Flavor & Fragrance Group Co Ltd
SSE:603020
|
CN |
|
I
|
Interglobe Aviation Ltd
BSE:539448
|
IN |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TOT BIOPHARM International Co Ltd's stock price target?
Not Available
TOT BIOPHARM International Co Ltd doesn't have any price targets made by Wall Street professionals.
What is TOT BIOPHARM International Co Ltd's Revenue forecast?
Projected CAGR
22%
For the last 6 years the compound annual growth rate for TOT BIOPHARM International Co Ltd's revenue is 74%. The projected CAGR for the next 2 years is 22%.
What is TOT BIOPHARM International Co Ltd's Operating Income forecast?
Projected CAGR
104%
The compound annual growth rate of TOT BIOPHARM International Co Ltd's operating income for the next 2 years is 104%.
What is TOT BIOPHARM International Co Ltd's Net Income forecast?
Projected CAGR
102%
The compound annual growth rate of TOT BIOPHARM International Co Ltd's net income for the next 2 years is 102%.
